SEC Comment Letter 0000000000-23-007459 to Evolent Health, Inc. (EVH)
Evolent Health, Inc.
Date: July 12, 2023 · CIK: 0001628908 · Accession: 0000000000-23-007459
AI Filing Summary & Sentiment
File numbers found in text: 001-37415
Letter
United States securities and exchange commission logo July 12, 2023 John Johnson Chief Financial Officer Evolent Health, Inc. 800 N Glebe Road, Suite 500 Arlington, VA 22203 Re:Evolent Health, Inc. Form 10-K for the Fiscal Year Ended December 31, 2022 Filed February 24, 2023 File No. 001-37415 Dear John Johnson: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Trade & Services
Show Raw Text
United States securities and exchange commission logo
July 12, 2023
John Johnson
Chief Financial Officer
Evolent Health, Inc.
800 N Glebe Road, Suite 500
Arlington, VA 22203
Re:Evolent Health, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2022
Filed February 24, 2023
File No. 001-37415
Dear John Johnson:
We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Trade & Services